$NSRCF
NextSource Materials Inc.

2017 Q3 Form 10-Q Financial Statement

#000143774917019342 Filed on November 14, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2017 Q2 2016 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $510.0K $1.190M $210.0K
YoY Change 142.86% 283.87% -25.0%
% of Gross Profit
Research & Development $290.0K $380.0K $310.0K
YoY Change -6.45% 80.95% 72.22%
% of Gross Profit
Depreciation & Amortization $1.748K $0.00 $11.00K
YoY Change -84.11% -100.0% -45.0%
% of Gross Profit
Operating Expenses $780.6K $1.440M $583.2K
YoY Change 33.84% 171.7% 21.51%
Operating Profit -$780.6K -$583.2K
YoY Change 33.84%
Interest Expense $30.00K $50.00K -$10.00K
YoY Change -400.0% -68.75% -101.89%
% of Operating Profit
Other Income/Expense, Net $0.00 -$130.0K -$30.00K
YoY Change -100.0%
Pretax Income -$780.0K -$1.520M -$580.0K
YoY Change 34.48% 406.67% -1260.0%
Income Tax
% Of Pretax Income
Net Earnings -$780.6K -$1.520M -$559.7K
YoY Change 39.47% 405.06% -1219.42%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.02 -$0.03 -$0.01
COMMON SHARES
Basic Shares Outstanding 461.0M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q3 2017 Q2 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.380M $1.960M $4.640M
YoY Change -70.26% 262.96% 518.67%
Cash & Equivalents $1.377M $1.965M $4.642M
Short-Term Investments
Other Short-Term Assets $40.00K $40.00K $40.00K
YoY Change 0.0% 300.0% 33.33%
Inventory
Prepaid Expenses $37.00K $39.10K
Receivables $130.8K $39.44K $20.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.545M $2.043M $4.700M
YoY Change -67.12% 258.31% 480.25%
LONG-TERM ASSETS
Property, Plant & Equipment $26.06K $27.81K $10.91K
YoY Change 138.84% 26.9% -78.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $26.06K $27.81K $10.00K
YoY Change 160.57% 26.9% -83.33%
TOTAL ASSETS
Total Short-Term Assets $1.545M $2.043M $4.700M
Total Long-Term Assets $26.06K $27.81K $10.00K
Total Assets $1.571M $2.071M $4.710M
YoY Change -66.64% 249.75% 441.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $192.5K $159.1K $150.0K
YoY Change 28.36% -26.11% 66.67%
Accrued Expenses $202.9K $68.24K $20.00K
YoY Change 914.27% 175.8% -93.94%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $590.0K $410.0K $410.0K
YoY Change 43.9% -22.64% -67.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $590.0K $410.0K $410.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $585.8K $410.3K $410.0K
YoY Change 42.88% -23.16% -67.2%
SHAREHOLDERS EQUITY
Retained Earnings -$98.74M -$97.96M
YoY Change 4.26%
Common Stock $462.5K $461.0K
YoY Change 26.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $985.4K $1.661M $4.306M
YoY Change
Total Liabilities & Shareholders Equity $1.571M $2.071M $4.710M
YoY Change -66.64% 249.75% 441.38%

Cashflow Statement

Concept 2017 Q3 2017 Q2 2016 Q3
OPERATING ACTIVITIES
Net Income -$780.6K -$1.520M -$559.7K
YoY Change 39.47% 405.06% -1219.42%
Depreciation, Depletion And Amortization $1.748K $0.00 $11.00K
YoY Change -84.11% -100.0% -45.0%
Cash From Operating Activities -$587.6K -$710.0K -$710.2K
YoY Change -17.26% 36.54% 34.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $5.178M
YoY Change -100.0% 1162.9%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 4.807M
YoY Change -100.0% 1072.49%
NET CHANGE
Cash From Operating Activities -587.6K -710.0K -710.2K
Cash From Investing Activities 0.000
Cash From Financing Activities 0.000 4.807M
Net Change In Cash -587.6K -710.0K 4.097M
YoY Change -114.34% -336.67% -10342.52%
FREE CASH FLOW
Cash From Operating Activities -$587.6K -$710.0K -$710.2K
Capital Expenditures $0.00
Free Cash Flow -$710.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
159147
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
130806
CY2017Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
202853
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
68241
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
173650
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
184651
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1748
us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
195561
CY2017Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
99263628
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
99160128
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
794864
CY2016Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
370671
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
70821256
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
74991256
CY2016Q3 us-gaap Professional Fees
ProfessionalFees
143717
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
27805
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
195561
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
195561
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
195561
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39441
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27805
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27805
CY2017 nsrc Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised
CY2017Q3 nsrc Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised
0.07
CY2017 nsrc Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Expired
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired
0.14
CY2017Q3 nsrc Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Expired
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired
CY2017 nsrc Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssued
CY2017Q3 nsrc Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssued
CY2017Q3 nsrc Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
1500000
CY2017 nsrc Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
CY2017Q3 nsrc Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
1500000
CY2017 nsrc Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
34721175
CY2017Q3 nsrc Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
CY2017 nsrc Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
CY2017Q3 nsrc Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
CY2017Q3 nsrc Contingency Provision
ContingencyProvision
190433
CY2017Q2 nsrc Contingency Provision
ContingencyProvision
182883
CY2017Q3 nsrc Net Working Capital
NetWorkingCapital
959337
CY2017Q2 nsrc Net Working Capital
NetWorkingCapital
1633214
CY2014 nsrc Number Of Flowthrough Shares Issued To Eligible Canadian Taxpayer Subscribers
NumberOfFlowthroughSharesIssuedToEligibleCanadianTaxpayerSubscribers
17889215
CY2017Q3 nsrc Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
1500000
CY2017Q3 nsrc Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
105000
CY2017Q3 nsrc Warrant Term
WarrantTerm
P182D
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
192539
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21911
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10910
CY2017Q3 us-gaap Assets
Assets
1571219
CY2017Q2 us-gaap Assets
Assets
2071290
CY2017Q3 us-gaap Assets Current
AssetsCurrent
1545162
CY2017Q2 us-gaap Assets Current
AssetsCurrent
2043485
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1377353
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1964948
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
544813
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4641821
CY2017Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-587595
CY2016Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4097008
CY2017Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.12
CY2016Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.13
CY2017Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.11
CY2017Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
29021256
CY2017Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
30521256
CY2016Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
65242431
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
462496
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
460996
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-780625
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-559709
CY2017Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
650000000
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
650000000
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
462495711
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
460995711
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
462495711
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
460995711
CY2017Q3 us-gaap Depreciation
Depreciation
1748
CY2016Q3 us-gaap Depreciation
Depreciation
11001
us-gaap Depreciation
Depreciation
10910
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1571219
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2071290
CY2017Q3 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
7550
CY2016Q3 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
-1769
CY2017Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
CY2016Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4807214
CY2017Q3 us-gaap Exploration Expense Mining
ExplorationExpenseMining
293609
CY2016Q3 us-gaap Exploration Expense Mining
ExplorationExpenseMining
313107
CY2017Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
CY2016Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-57166
CY2017Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
28935
CY2016Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-53236
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
153916
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
62184
CY2017Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
168004
CY2016Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-67595
CY2017Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15728
CY2016Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
34968
CY2017Q3 us-gaap Liabilities
Liabilities
585825
CY2017Q2 us-gaap Liabilities
Liabilities
410271
CY2016Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
CY2017Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-587595
CY2016Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-710206
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-780625
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-559709
us-gaap Net Income Loss
NetIncomeLoss
-3439649
CY2017Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
780625
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
583245
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-780625
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-583245
CY2017Q3 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1748
CY2016Q3 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
11001
CY2017Q3 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
CY2016Q3 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
33630
CY2017Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
CY2016Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
370671
CY2017Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
37003
CY2017Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
39096
CY2017Q3 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
CY2016Q3 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
CY2017Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2016Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5177885
CY2017Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
105000
CY2017Q3 us-gaap Professional Fees
ProfessionalFees
360287
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27805
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26057
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-98740730
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97960105
CY2017Q3 us-gaap Revenues
Revenues
0
CY2016Q3 us-gaap Revenues
Revenues
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.11
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2017Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.23
CY2017Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.18
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
18635000
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.07
CY2017Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P3Y146D
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
46000000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2670000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
21140000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
41800000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
44470000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
41965000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.10
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.18
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2017Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
58299
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
4305804
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
1661019
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
985394
CY2017Q3 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of these <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">unaudited condensed consolidated interim financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of these unaudited condensed consolidated interim financial statements and the reported amounts of revenues and expenses during the period. On an ongoing basis, management evaluates its judgments and estimates in relation to assets, liabilities, revenue and expenses. Management uses past experience and other factors as the basis for its judgments and estimates. Actual results <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>differ from those estimates. The impacts of estimates are pervasive throughout these unaudited condensed consolidated interim financial statements and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>require accounting adjustments based on future occurrences. Revisions to accounting estimates are recognized in the period in which the estimate is revised and the revision affects current and future periods. Areas where significant estimates and assumptions are used include: the binomial valuation of the warrant liability, the Black-Scholes valuation of warrants and stock options, the valuation recorded for future income taxes and the assumption that the Company will receive title to the properties after the Madagascar political situation stabilizes.</div></div></div></div>
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
460995711
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
409761425

Files In Submission

Name View Source Status
0001437749-17-019342-index-headers.html Edgar Link pending
0001437749-17-019342-index.html Edgar Link pending
0001437749-17-019342.txt Edgar Link pending
0001437749-17-019342-xbrl.zip Edgar Link pending
ex_99682.htm Edgar Link pending
ex_99683.htm Edgar Link pending
ex_99684.htm Edgar Link pending
ex_99685.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nextsource.jpg Edgar Link pending
nsrc-20170930.xml Edgar Link completed
nsrc-20170930.xsd Edgar Link pending
nsrc-20170930_cal.xml Edgar Link unprocessable
nsrc-20170930_def.xml Edgar Link unprocessable
nsrc-20170930_lab.xml Edgar Link unprocessable
nsrc-20170930_pre.xml Edgar Link unprocessable
nsrc20170930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending